Literature DB >> 2138276

Heterodimer formation between CREB and JUN proteins.

D M Benbrook1, N C Jones.   

Abstract

DNA binding protein families have been identified that contain a leucine zipper dimerization motif preceded by a conserved, highly basic domain involved in direct specific interaction with DNA. Members of two of these families, the Jun and Fos related proteins, have been shown to directly interact and form heterodimeric complexes. A third such family known as the CREB or ATF proteins, bind to a sequence element present in promoters from a number of viral and cellular genes; this element can confer cAMP-inducibility and E1A-inducibility of transcription. In this report we show that one member of the CREB family can efficiently form a heterodimeric complex with the cJun protein. The DNA binding specificity of the heterodimer was indistinguishable from CREB alone. Transfection studies in undifferentiated F9 cells suggest that the CREB/cJun heterodimer can form in vivo, but that the complex does not activate transcription. The heterodimer formation between CREB and Jun proteins is highly specific; only one of the two CREB proteins would heterodimerize with cJun and it would not form dimers with JunB or cFos. The interaction of members of these two families of proteins increases the repertoire of possible regulatory complexes that could play an important role in the regulation of transcription of specific cellular genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138276

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  107 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  An alternative model of H ferritin promoter transactivation by c-Jun.

Authors:  Maria C Faniello; Giuseppa Chirico; Barbara Quaresima; Giovanni Cuda; Giovanna Allevato; Maria A Bevilacqua; Francesco Baudi; Vittorio Colantuoni; Filiberto Cimino; Salvatore Venuta; Vittorio E Avvedimento; Francesco Costanzo
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

3.  Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.

Authors:  C Van Lint; C A Amella; S Emiliani; M John; T Jie; E Verdin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer.

Authors:  K Georgopoulos; B A Morgan; D D Moore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

Review 5.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

6.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.

Authors:  S l Fu; I Bottoli; M Goller; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

8.  Transcriptional repression by a novel member of the bZIP family of transcription factors.

Authors:  I G Cowell; A Skinner; H C Hurst
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

9.  Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.

Authors:  F Beier; R J Lee; A C Taylor; R G Pestell; P LuValle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 10.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.